Rassu, Mauro

Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype. [electronic resource] - Journal of cellular and molecular medicine 12 2019 - 8505-8510 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1582-4934

10.1111/jcmm.14674 doi


Animals
Anticonvulsants--pharmacology
Cell Line, Tumor
Cells, Cultured
Epilepsy--drug therapy
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2--genetics
Levetiracetam--pharmacology
Membrane Glycoproteins--metabolism
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Mutation
Nerve Tissue Proteins--metabolism
Neurites--drug effects
Neurons--drug effects
PC12 Cells
Parkinson Disease--drug therapy
Protein Binding
Rats
Signal Transduction--drug effects
Synaptic Vesicles--metabolism